GlassScriptPhysician profile
Michelle E Nagel
NPI 1033580865
$6,777.72
in general payments reported to CMS, 2019-2025
39 companies · $642 in 2025
The $642 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,520 · 2022: $1,404 · 2023: $1,479 · 2024: $1,732 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,853.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,995.98 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $639.88 | 2022-2025 | Qelbree, Qelbree |
| Novo Nordisk INC | $494.01 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Gilead Sciences, INC. | $444.75 | 2021-2025 | |
| Corium, LLC | $324.01 | 2022-2025 | Azstarys |
| Pfizer INC. | $314.64 | 2022-2025 | |
| Lilly USA, LLC | $276.74 | 2021-2024 | Mounjaro, Zepbound, Trulicity |
| Viiv Healthcare Company | $247.27 | 2022-2024 | Apretude |
| Bausch Health US, LLC | $226.10 | 2021-2025 | Aplenzin, Wellbutrin |
| Takeda Pharmaceuticals U.S.A., INC. | $196.18 | 2021-2023 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $166.32 | 2021 | |
| Ironshore Pharmaceuticals INC. | $155.14 | 2021-2024 | Jornay Pm |
| Neos Therapeutics, LP | $108.49 | 2021-2024 | Adzenys Xr-Odt |
| Noven Therapeutics, LLC | $105.05 | 2023-2025 | Xelstrym, Secuado |
| Teva Pharmaceuticals USA, INC. | $102.69 | 2021-2023 | Austedo |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $91.04 | 2021-2025 | Trelegy Ellipta, Pediarix, Rotarix |
| Astrazeneca Pharmaceuticals LP | $90.93 | 2024-2025 | Airsupra, Breztri |
| Amgen INC. | $78.59 | 2022 | |
| Axsome Therapeutics, INC. | $67.18 | 2023-2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $63.56 | 2022 | |
| Idorsia Pharmaceuticals US INC | $61.35 | 2022-2024 | Quviviq |
| Exact Sciences Corporation | $60.58 | 2023-2024 | Cologuard Collection Kit |
| Lundbeck LLC | $47.75 | 2024-2025 | Rexulti |
| Inspire Medical Systems, INC. | $46.74 | 2024-2025 | Inspire |
| Agile Therapeutics, INC. | $40.06 | 2023-2024 | Twirla |
| Tris Pharma INC | $36.73 | 2023-2024 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $34.75 | 2025 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $30.88 | 2021 | |
| Jazz Pharmaceuticals INC. | $30.47 | 2021 | |
| Corcept Therapeutics | $30.19 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $23.62 | 2022 | |
| Merck Sharp & Dohme LLC | $23.32 | 2025 | Gardasil 9, Capvaxive |
| Redhill Biopharma INC. | $22.86 | 2021 | |
| Alfasigma USA, INC. | $20.33 | 2021 | |
| Phadia US INC. | $18.62 | 2021 | |
| Ibsa Pharma INC. | $17.51 | 2024 | Tirosint, Licart |
| Coopersurgical, INC. | $16.16 | 2021 | |
| Highridge Medical LLC | $14.22 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Organon LLC | $13.03 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Nagel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.